131I-Metaiodobenzylguanidine (131I-MIBG) Therapy for Refractory Neuroblastoma and Pheochromocytoma
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Iobenguane (Primary) ; Pegfilgrastim; Potassium iodide
- Indications Neuroblastoma; Phaeochromocytoma
- Focus Adverse reactions
- 22 Jan 2021 Biomarkers information updated
- 20 May 2013 New trial record